ArticleRheumatology and therapy2019

Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study.

Jean Darloy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.